Cargando…
A fatal case report of invasive pulmonary aspergillosis and mucormycosis coinfection in an immunocompetent patient with coronavirus disease 2019 in Korea
Systemic glucocorticoid treatment is highly recommended in critically ill coronavirus disease 2019 (COVID-19) patients. However, secondary fungal infections are of concern in such patients. Here, we describe the first case of COVID-19-associated invasive pulmonary aspergillosis (CAPA) and COVID-19-a...
Autores principales: | Kim, Jin Hyoung, Kim, Misung, Lim, Soyeoun, Park, Sun Young, Jegal, Yangjin, Lee, Taehoon, Kang, Byung Ju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Critical Care Medicine
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497891/ https://www.ncbi.nlm.nih.gov/pubmed/35791656 http://dx.doi.org/10.4266/acc.2021.01340 |
Ejemplares similares
-
Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient
por: Blaize, Marion, et al.
Publicado: (2020) -
Immune Checkpoint Blockade for Aspergillosis and Mucormycosis Coinfection
por: Banck, Jan Christoph, et al.
Publicado: (2021) -
Isolated cerebral Mucormycosis and Aspergillosis coinfection in an immunocompromised adult
por: Sun, George, et al.
Publicado: (2023) -
Coinfection pulmonary mucormycosis and aspergillosis with disseminated mucormycosis involving gastrointestinalin in an acute B-lymphoblastic leukemia patient
por: Hu, Zhi-min, et al.
Publicado: (2021) -
Concomitant orbital aspergillosis and mucormycosis in a 17 months old immunocompetent child
por: Habroosh, Fatima A., et al.
Publicado: (2017)